E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/5/2015 in the Prospect News Structured Products Daily.

Bank of Montreal plans 7.2% autocallables tied to Nasdaq Biotech ETF

New York, Oct. 5 – Bank of Montreal plans to price 7.2% autocallable cash-settled notes with fixed interest payments due Oct. 31, 2016 linked to the iShares Nasdaq Biotechnology exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.

Interest will be payable monthly.

The notes will be called at par if the fund closes above the 110% call level on any monthly call date starting Feb. 24, 2016.

The payout at maturity will be par unless the fund closes below the 70% trigger level at any time during the life of the notes, in which case investors will be fully exposed to any losses.

BMO Capital Markets Corp. is the agent.

The notes will price on Oct. 27 and settle on Oct. 30.

The Cusip number is 06366R2V6.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.